您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
REA / Bioactive Compounds

Human OX40 (CD134) Protein (C-Fc)

Human OX40 (CD134) Protein (C-Fc)

英诺赛图(InnoCyto)的 Human OX40 (CD134) Protein (C-Fc),属于生物活性物质,靶点/物种 OX40(别名 TNFRSF4 等),表达宿主 HEK293,C-Fc 标签,纯度 >95% based on SDS-PAGE under reducing condition,适用于酶联免疫(ELISA)。提供 25 μg、100 μg 规格,目录价 ¥983 起,仅供科研使用(RUO)。

科学仪器 供应商 上海英诺赛图 ↗ 型号 604601 更新 2026-11-12
参考价格区间
¥983
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Human OX40 (CD134) Protein (C-Fc),属于生物活性物质,靶点/物种 OX40(别名 TNFRSF4 等),表达宿主 HEK293,C-Fc 标签,纯度 >95% based on SDS-PAGE under reducing condition,适用于酶联免疫(ELISA)。提供 25 μg、100 μg 规格,目录价 ¥983 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

604601 | 25 μg | ¥983

604602 | 100 μg | ¥2,000

Product Details

Molecular Weight|This protein has a predicted molecular weight of 46.5 kDa. Under DTT-reducing conditions, the protein migrates at approximately 65 kDa on SDS-PAGE.

Regulatory Status|RUO

Protein Concentration|25µg size is bottled at 0.2mg/mL concentration. 100 µg size is supplied at a lot-specific concentration.

Storage and Handling|Briefly centrifuge the vial upon receipt. An unopened vial can be stored at 4°C for up to 2 weeks, or at -20°C or below for up to six months. The protein may be further diluted to 0.1 mg/mL using 0.22 µm-filtered PBS buffer (pH 7.4). For long-term storage, the diluted stock solution should be aliquoted and stored at ≤ –70°C to minimize freeze-thaw cycles. If additional dilution is required, carrier proteins such as FBS or BSA should be added to maintain protein stability.

Background Information

OX40, also known as CD134 or TNFRSF4, is a co-stimulatory receptor that plays a key role in regulating T cell activation, survival, and memory formation. OX40 is not expressed on resting naïve T cells but is rapidly upregulated on CD4+ and CD8+ T cells following antigen recognition and co-stimulation. It is also expressed on regulatory T cells and, in some contexts, on innate immune cells. Through its signaling, OX40 enhances the magnitude and durability of adaptive immune responses.

Structurally, OX40 is a type I transmembrane glycoprotein and a member of the tumor necrosis factor receptor (TNFR) superfamily. Its extracellular region contains multiple cysteine-rich domains characteristic of TNFR family members, which mediate ligand binding. OX40 has a single transmembrane domain and a cytoplasmic tail that lacks intrinsic enzymatic activity but recruits TNF receptor–associated factors (TRAFs) upon activation. These adaptor proteins initiate downstream signaling pathways, including NF-κB, PI3K–AKT, and MAPK pathways, which promote T cell proliferation, survival, and cytokine production.

The primary ligand for OX40 is OX40 ligand (OX40L, also known as CD252 or TNFSF4), which is expressed on activated antigen-presenting cells such as dendritic cells, B cells, and macrophages, as well as on endothelial cells in inflamed tissues. Engagement of OX40 by OX40L delivers a potent co-stimulatory signal that supports clonal expansion of effector T cells, enhances the generation of long-lived memory T cells, and can modulate the suppressive function of regulatory T cells.

OX40 signaling is implicated in a range of disease processes. In autoimmune and inflammatory diseases, excessive or prolonged OX40–OX40L interactions can drive pathogenic T cell responses, contributing to chronic inflammation and tissue damage. In allergic disease, OX40 promotes Th2 differentiation and cytokine production, supporting allergic inflammation. Conversely, in cancer, insufficient OX40 signaling may limit effective anti-tumor immunity, as robust T cell activation and persistence are required for tumor control.

Therapeutically, OX40 is an active target of immunomodulatory strategies. Agonistic antibodies targeting OX40 are being developed to enhance T cell responses in cancer immunotherapy, often in combination with immune checkpoint inhibitors to improve efficacy. In contrast, blockade of the OX40–OX40L pathway is being explored as a potential treatment for autoimmune and inflammatory diseases. These dual approaches underscore OX40’s central role in balancing immune activation and regulation in health and disease.

Data Sheets

Purified Human OX40 Protein (C-Fc) on SDS-PAGE under reducing (P+) and non-reducing (P-) conditions. The purity of the purified protein appears to be greater than 95% based on reducing condition.

规格明细:Storage and Handling — Briefly centrifuge the vial upon receipt. An unopened vial can be stored at 4°C for up to 2 weeks, or at -20°C or below for up to six months. The protein may be further diluted to 0.1 mg/mL using 0.22 µm-filtered PBS buffer (pH 7.4). For long-term storage, the diluted stock solution should be aliquoted and stored at ≤ –70°C to minimize freeze-thaw cycles. If additional dilution is required, carrier proteins such as FBS or BSA should be added to maintain protein stability.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 μg
ApplicationELISA, BLI
FormatLiquid, Purified
Expression HostHEK293
Target NameOX40, TNFRSF4, OX40L receptor, CD134, ACT35
SpeciesHuman
Accession NumberNP_003318
SourcesRecombinant Human OX40 (Lue29-Ala216 ) with C-terminus Fc tag is expressed in 293 cells
Affinity TagC-Fc
Purity>95% based on SDS-PAGE under reducing condition
Regulatory StatusRUO
Formulation1xPBS buffer, pH7.4, 0.22 µm filtered
Endotoxin levelLess than 0.1 EU/µg protein as determined by the LAL method
Protein Concentration25µg size is bottled at 0.2mg/mL concentration. 100 µg size is supplied at a lot-specific concentration.
目录价¥983

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Human OX40 (CD134) Protein (C-Fc)(604601)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/human-ox40-cd134-protein-c-fc.html.
TeleVM. (2026, November 12). Human OX40 (CD134) Protein (C-Fc)(604601). 产品目录. https://www.suprotek.cn/products/item/human-ox40-cd134-protein-c-fc.html
@misc{biocsp_item_human_ox40_cd134_protein_c_fc,
  title        = {Human OX40 (CD134) Protein (C-Fc)(604601)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/human-ox40-cd134-protein-c-fc.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Human OX40 (CD134) Protein (C-Fc)

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。